LILLY EXPANDS INSULIN AFFORDABILITY OPTIONS Lower-priced insulins and other options for people with diabetes who need help affording their Lilly insulin.
Millions of Americans with high-deductible insurance plans are facing high out-of-pocket costs because their plans reset at the beginning of the year. Individuals on these plans are sometimes forced to make tough decisions when it comes to their health. Well, there is some hope, there’s one company committed to helping those who face the higher out-of-pocket costs afford their Lilly insulin. GUEST:
Andy Vicari is Senior Director & U.S. Brand Leader for the Insulins portfolio at Eli Lilly and Company. In this role, Andy leads the brand teams in developing and executing cross-portfolio marketing strategies across various insulin brands at Lilly. Andy has held several leadership positions in sales and marketing. Outside of work, Andy serves on the Board of Directors for the American Diabetes Association. He earned a bachelor’s degree in Biomedical Sciences from St. Cloud State University and a Master of Business Administration from the University of Illinois at Urbana-Champaign
